About 3 results found for searched term "GSK852" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21182 | GSK852 | Epigenetic Reader Domain |
| GSK852 is a very potent selective BET inhibitor of BD2 (pIC50 = 7.9). | ||
| M24779 | Dezamizumab | Others |
| GSK 2398852; Anti-Serum Amyloid P/SAP Reference Antibody | ||
| Dezamizumab (GSK 2398852) is a fully humanized recombinant monoclonal IgG1 anti-serum amyloid P component (SAP) antibody, with potential anti-amyloid activity. Dezamizumab triggers immunotherapeutic clearance of amyloid. Dezamizumab can be used in research of Amyloid light-chain (AL) amyloidosis. | ||
| M28183 | GSK5852 | Anti-infection |
| GSK2485852 | ||
| GSK5852 (GSK2485852) is an HCV NS5B polymerase inhibitor, with an IC50 value of 50 nM. GSK5852 displays antiviral activity and inhibits HCV with EC50s of 3.0 nM (genotype 1a, GT1a) and 1.7 nM (GT1b), respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
